DCOY

Decoy Therapeutics Inc.

10 transactions on file, per SEC Form 4 filings.

Burleson Tess

director · 2026-08-31

Award

2,000 sh

Lieber Jonathan I

director · 2026-08-31

Award

2,000 sh

PIERCE FREDERICK II

Chief Executive Officer · 2026-08-31

Award

33,455 sh

Marschel Peter Klaus

Chief Business Officer · 2026-08-31

Award

3,900 sh

Rosenblum Mark J

Chief Financial Officer · 2026-08-31

Award

9,682 sh

Hibner Barbara Louise

Chief Scientific Officer · 2026-08-31

Award

4,216 sh

HANISH ARNOLD C

director · 2026-08-31

Award

3,000 sh

Lammers Paul

director · 2026-08-31

Award

2,000 sh

McVicar William K.

director · 2026-08-31

Award

3,000 sh

Gauthier Patricia G.

director · 2026-08-31

Award

2,000 sh

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is DCOY actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.